OptimizeRx(OPRX) - 2023 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | Nevada | 001-38543 | 26-1265381 | | --- | --- | --- | | (State or other jurisdiction | (Commission File Number) | (IRS Employer | | of incorporation) | | Identification No.) | ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 260 Charles Street, Suite 302, Waltham, MA 02453 (Address of principal executiv ...